The Design of Clinical Trials in Portal Hypertension. | Semantic Scholar
Liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension - JHEP Reports
PLOS ONE: Non-invasive assessment of portal hypertension by multi-parametric magnetic resonance imaging of the spleen: A proof of concept study
β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial - The Lancet
Similar performance of liver stiffness measurement and liver surface nodularity for the detection of portal hypertension in patients with hepatocellular carcinoma - JHEP Reports
Exalenz Bioscience Announces Positive Clinical Trial
Regression of portal hypertension: underlying mechanisms and therapeutic strategies | SpringerLink
Non-invasive assessment of portal hypertension by multi-parametric magnetic resonance imaging of the spleen: A proof of concept study
The portal hypertension syndrome: etiology, classification, relevance, and animal models | Semantic Scholar
Portal Hypertension and Related Complications: Diagnosis and Management - Mayo Clinic Proceedings
Core Concepts - Screening for Varices and Prevention of Bleeding - Management of Cirrhosis-Related Complications - Hepatitis C Online
Abbreviations: CSPH, clinical significant portal hypertension; APRI,... | Download Scientific Diagram
Should patients with clinically significant portal hypertension be on beta-blockers? | Liver Fellow Network
CSPH - Clinically Significant Portal Hypertension
Noninvasive Detection of Clinically Significant Portal Hypertension in Compensated Advanced Chronic Liver Disease - Clinics in Liver Disease
Non invasive evaluation of portal hypertension using transient elastography - ScienceDirect
Portal Hypertension | Abdominal Key
Clinical role of non-invasive assessment of portal hypertension
The Value of Liver and Spleen Stiffness for Evaluation of Portal Hypertension in Compensated Cirrhosis - Reiberger - - Hepatology Communications - Wiley Online Library
Serum keratin 19 (CYFRA21-1) links ductular reaction with portal hypertension and outcome of various advanced liver diseases | BMC Medicine | Full Text
Noninvasive Detection of Clinically Significant Portal Hypertension in Compensated Advanced Chronic Liver Disease - Clinics in Liver Disease
Emerging non-invasive approaches for diagnosis and monitoring of portal hypertension - The Lancet Gastroenterology & Hepatology
Solved In a crossover trial, 19 patients with clinically | Chegg.com
Clinically significant portal hypertension in cirrhosis patients with COVID-19: Clinical characteristics and outcomes - Journal of Infection
Algorithm to rule out clinically significant portal hypertension combining Shear-wave elastography of liver and spleen: a prospective multicentre study | Gut
Frontiers | Plasma Cyclic Guanosine Monophosphate Is a Promising Biomarker of Clinically Significant Portal Hypertension in Patients With Liver Cirrhosis | Medicine
